conversationHEALTH Announces Key Hires to Accelerate Global Growth  and Expansion  

April 23, 2021 (Toronto, ON) - conversationHEALTH, the conversational AI platform purpose built for the Life Sciences industry has announced it is scaling growth across all divisions of the  organization in North America, Europe, and Asia-Pacific. This includes the hiring of Chery Burt,  VP, Strategy to lead thought leadership and go-to-market planning with customers and partners,  and Kei Kubo, Managing Director of APAC, to lead business development and build strategic  partnerships across the Asia-Pacific market.  

Cheryl Burt Kei Kubo  

“I am delighted to welcome Chery Burt, Kei Kubo and all the new hires to the  conversationHEALTH team. As we continue to expand our Life Sciences customer base  globally, their multifaceted background in healthcare and strategic business acumen, is the  perfect match for our company” states Richard Marcil, Chief Customer Officer of  conversationHEALTH.  

Cheryl Burt is a marketing and strategy veteran with 20 years experience in the health and  wellness sector. She has held local and regional marketing roles as well as global strategy roles  in her career, including senior product roles at Johnson & Johnson. Most recently, Cheryl was  VP of Marketing, Innovation and Digital Strategy at Bayer Consumer Health Canada.  

“I am very excited to join conversationHEALTH at what feels like an inflection point in the Life  Sciences industry. I look forward to collaborating with Pharma, Biotech and Medical Devices  teams to reimagine and reinvent how they engage with their customers and patients in an  impactful and scalable way for true value creation” notes Burt. 

Kei Kubo has held a number of senior leadership roles in international business development  and marketing. After working as a corporate strategist at Dentsu in Japan, he transferred to the  Canadian Branch as Vice President of International Development, successfully leading the  global expansion of several top tier clients in the IoT, manufacturing and consumer goods  industry. Kei has also worked as an Investment Advisor of JETRO Canada, Japanese External  Trade Organization, providing support to start-up and venture companies, particularly in AI and  other high-tech industries within Canada.  

“In my role as Managing Director, APAC, I am looking forward to bringing conversational AI  solutions to the Life Sciences industry in the Asia-Pacific market, and strongly believe we have  the ability to change the way this industry does business as they deploy AI agents for customers  and patients to easily access medical and product information - when and where they need it”  states Kubo.  

As Life Sciences companies continue to expand digital engagement with employees,  customers, and patients, conversationHEALTH is deploying sophisticated AI agents that work  hand-in-hand with them for 24/7/365 support of medical information, education and service, all  for better health outcomes.  

To learn more about conversationHEALTH’s conversational AI solutions for the Life Sciences  industry, visit: conversationhealth.com  

About conversationHEALTH:  

conversationHEALTH is a group of life sciences experts, artificial intelligence engineers,  software developers, data scientists and conversational architects that, together, are building  industry-changing conversational AI solutions. The conversationHEALTH SaaS platform is  purpose-built for the life sciences industry, and sets the standard in terms of accuracy and  compliance with medically-trained taxonomies, data sets, NLP and technical stack. The  platform also integrates with all major software providers in the life sciences industry, who are  deploying conversational agents in clinical trials, medical affairs and commercial lines of  business.  

conversationHEALTH is based in Toronto, Canada with offices in North America and in Europe.  For more information, visit conversationhealth.com  

For media inquiries contact:  

Jessica Naman  

Director of Marketing  

jessica@conversationhealth.com